Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy
Authors
Keywords
-
Journal
Substance Abuse
Volume 44, Issue 4, Pages 264-276
Publisher
SAGE Publications
Online
2023-10-30
DOI
10.1177/08897077231203849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Physician-Delegated Unobserved Induction with Buprenorphine in Pharmacies
- (2023) Traci C. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
- (2023) Lauren J. Tanz et al. JAMA Network Open
- Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021
- (2023) Christopher M. Jones et al. JAMA Network Open
- Description and Evaluation of a Pilot Advanced Pharmacy Practice Experience in Addiction Medicine
- (2022) Lindsey J. Loera et al. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION
- Evaluation of patient satisfaction and perceptions of a long-acting injectable antipsychotic medication administration service in a community-based pharmacy during the COVID-19 pandemic
- (2022) Leighton N. Mascari et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization
- (2022) Akshara Kumar et al. Health Research Policy and Systems
- State-level regulations and opioid-related health outcomes
- (2022) Joanna R. Jackson et al. DRUG AND ALCOHOL DEPENDENCE
- Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies
- (2022) Traci C. Green et al. Substance Abuse
- Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states
- (2022) Lucas G. Hill et al. DRUG AND ALCOHOL DEPENDENCE
- Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis
- (2022) Lucas A. Berenbrok et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019"
- (2022) Noa Krawczyk et al. INTERNATIONAL JOURNAL OF DRUG POLICY
- Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists
- (2022) Lucas G. Hill et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician
- (2022) Adriane N. Irwin et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Readiness of community pharmacies to implement an opioid safety intervention
- (2022) Anthony S. Floyd et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network
- (2021) Li‐Tzy Wu et al. ADDICTION
- Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic
- (2021) Alyssa M Peckham et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Wellness and Stigma: Pharmacy’s Ongoing Conflict
- (2021) Suzanne C. Harris et al. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION
- The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation
- (2021) Gail D'Onofrio et al. Contemporary Clinical Trials
- Pharmacists’ stigma toward patients engaged in opioid misuse: When “social distance” does not mean disease prevention
- (2021) Amy Werremeyer et al. Substance Abuse
- Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial
- (2021) Li‐Tzy Wu et al. ADDICTION
- Access to medication-assisted treatment in the United States: Comparison of travel time to opioid treatment programs and office-based buprenorphine treatment
- (2021) Solmaz Amiri et al. DRUG AND ALCOHOL DEPENDENCE
- Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden
- (2021) Neda J. Kazerouni et al. DRUG AND ALCOHOL DEPENDENCE
- Alternative use of buprenorphine among people who use opioids in three U.S. Cities
- (2021) Priyal Gandhi et al. Substance Abuse
- Revisiting the X
- (2021) Elizabeth M. Ajazi et al. Journal of Addiction Medicine
- Pilot testing a tool to determine the costs and time associated with community pharmacy-based administration of injectable naltrexone
- (2021) James H. Ford et al. Research in Social & Administrative Pharmacy
- Telepharmacy during COVID-19: A Scoping Review
- (2021) Elizabeth J. Unni et al. Pharmacy
- Indiana community pharmacist preceptors’ knowledge and perceptions of medication-assisted treatment
- (2020) Elizabeth S. Davenport et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study
- (2020) Paul J. Joudrey et al. DRUG AND ALCOHOL DEPENDENCE
- Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis
- (2020) Aaron Salwan et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic
- (2020) Gerald Cochran et al. Substance Abuse
- Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US
- (2020) Paul J. Joudrey et al. JAMA Psychiatry
- Reimbursement for pharmacist-provided health care services: A multistate review
- (2020) Elaine Nguyen et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder
- (2020) Beth M DeRonne et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Community pharmacy-based injectable naltrexone service delivery models and best practices
- (2020) James H. Ford et al. Research in Social & Administrative Pharmacy
- Strengthening the evidence-base on payment models for pharmacist-provided services
- (2019) Andy Stergachis JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- The Substance Use Intervention Team
- (2019) Hale M. Thompson et al. Journal of Addiction Medicine
- Making Amends for the Opioid Epidemic
- (2019) Joshua M. Sharfstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality
- (2019) Tamara Beetham et al. ANNALS OF INTERNAL MEDICINE
- Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort
- (2019) Jake R. Morgan et al. DRUG AND ALCOHOL DEPENDENCE
- Interprofessional Substance Use Disorder Education in Health Professions Education Programs
- (2019) Andrew Muzyk et al. ACADEMIC MEDICINE
- Pharmacy: Addressing substance use in the 21st century
- (2019) Jeffrey Bratberg Substance Abuse
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
- (2018) Marc R. Larochelle et al. ANNALS OF INTERNAL MEDICINE
- Applying American Society of Addiction Medicine Performance Measures in Commercial Health Insurance and Services Data
- (2018) Cindy Parks Thomas et al. Journal of Addiction Medicine
- Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update
- (2018) C. Holly A. Andrilla et al. JOURNAL OF RURAL HEALTH
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
- (2018) Joshua D Lee et al. LANCET
- Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees
- (2017) Amanda J. Abraham et al. HEALTH SERVICES RESEARCH
- An interprofessional education workshop to develop health professional student opioid misuse knowledge, attitudes, and skills
- (2017) Kristina Monteiro et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
- (2017) Luis Sordo et al. BMJ-British Medical Journal
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
- (2017) Luis Sordo et al. BMJ-British Medical Journal
- Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial
- (2016) Yih-Ing Hser et al. ADDICTION
- Treatment utilization among persons with opioid use disorder in the United States
- (2016) Li-Tzy Wu et al. DRUG AND ALCOHOL DEPENDENCE
- Missed Opportunities for HIV Screening in Pharmacies and Retail Clinics
- (2016) Caitlin Dugdale et al. JOURNAL OF MANAGED CARE PHARMACY
- Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England
- (2015) Matthias Pierce et al. ADDICTION
- A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence
- (2015) Natasa Gisev et al. ADDICTION
- Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002–11
- (2015) Andrew W. Dick et al. HEALTH AFFAIRS
- Physician–pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients
- (2015) Bethany A. DiPaula et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Mental Health And Addiction Workforce Development: Federal Leadership Is Needed To Address The Growing Crisis
- (2013) Michael A. Hoge et al. HEALTH AFFAIRS
- Medication-Assisted Treatment With Methadone: Assessing the Evidence
- (2013) Catherine Anne Fullerton et al. PSYCHIATRIC SERVICES
- Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
- (2013) Cindy Parks Thomas et al. PSYCHIATRIC SERVICES
- Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care
- (2012) Bruce R. Schackman et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia
- (2010) B. Vicknasingam et al. DRUG AND ALCOHOL DEPENDENCE
- Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy
- (2009) T.V. Parran et al. DRUG AND ALCOHOL DEPENDENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now